Ghp Investment Advisors, Inc. Eli Lilly & CO Transaction History

Ghp Investment Advisors, Inc.

$2.15 Billion
Q3 2024

A detailed history of Ghp Investment Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ghp Investment Advisors, Inc. holds 1,848 shares of LLY stock, worth $1.38 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,848

Previous 1,759 5.06%

Holding current value

$1.38 Million

Previous $1.59 Million 2.83%

% of portfolio

0.08%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $68,720 - $85,441	89 Added 5.06%	1,848 $1.64 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $3,624 - $4,545	5 Added 0.29%	1,759 $1.59 Million
Q1 2024 Apr 25, 2024	SELL	$592.2 - $792.28 $555,483 - $743,158	-938 Reduced 34.84%	1,754 $1.36 Million
Q4 2023 Jan 26, 2024	SELL	$525.19 - $619.13 $489,477 - $577,029	-932 Reduced 25.72%	2,692 $1.57 Million
Q3 2023 Oct 17, 2023	SELL	$434.7 - $599.3 $461,651 - $636,456	-1,062 Reduced 22.66%	3,624 $1.95 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $112,938 - $151,011	-322 Reduced 6.43%	4,686 $2.2 Million
Q1 2023 Apr 21, 2023	BUY	$310.63 - $364.82 $1.18 Million - $1.38 Million	3,790 Added 311.17%	5,008 $1.72 Million
Q4 2022 Feb 16, 2023	SELL	$321.55 - $374.67 $1,929 - $2,248	-6 Reduced 0.49%	1,218 $445,000
Q3 2022 Oct 28, 2022	SELL	$296.48 - $337.87 $11,266 - $12,839	-38 Reduced 3.01%	1,224 $396,000
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $836 - $981	3 Added 0.24%	1,262 $409,000
Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $10,326 - $12,833	-44 Reduced 3.38%	1,259 $360,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $224 - $279	1 Added 0.08%	1,303 $360,000
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $428,574 - $527,421	-1,934 Reduced 59.77%	1,302 $301,000
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $36,290 - $46,941	-201 Reduced 5.85%	3,236 $743,000
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $49,460 - $64,028	301 Added 9.6%	3,437 $642,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $6,392 - $8,458	-49 Reduced 1.54%	3,136 $530,000
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $7,457 - $8,625	51 Added 1.63%	3,185 $471,000
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $119 - $147	1 Added 0.03%	3,134 $435,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $106 - $132	1 Added 0.03%	3,133 $412,000
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $106 - $116	1 Added 0.03%	3,132 $350,000
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $4,320 - $5,043	-39 Reduced 1.23%	3,131 $347,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $352,852 - $415,333	3,170 New	3,170 $411,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghp Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ghp Investment Advisors, Inc. with notifications on news.

Account

Ghp Investment Advisors, Inc. Eli Lilly & CO Transaction History